Petra Pharma announces licensing agreement with Takeda Pharmaceutical Company

Deal expands Petra's portfolio, accelerating progress to Phase 2 clinical stage company Maximizes opportunity for lead candidate, serabelisib, in targeting PIK3CA-mutated solid tumors NEW YORK, March 20, 2019 -- (Healthcare Sales & Marketing Network)... Biopharmaceuticals, Licensing Petra Pharma, Takeda Pharmaceutical, serabelisib
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news